The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen
A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients: The RAMTAS trial of the German AIO (KRK-0316).
 
Stefan Kasper
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Roche; Shire; Shire
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck Serono; Roche; Sanofi
Other Relationship - Amgen; Merck Serono; Sanofi
 
Gerrit zur Hausen
No Relationships to Disclose
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical; Takeda
 
Andreas Berger
No Relationships to Disclose
 
Sonja Loges
Honoraria - Sanofi
Consulting or Advisory Role - Abbvie; AstraZeneca; BerGenBio; Bristol-Myers Squibb; Chugai Pharma; Lilly; Medac; Novartis; Roche Pharma AG
Speakers' Bureau - Boehringer Ingelheim
Research Funding - BerGenBio; Lilly; Roche Pharma AG
 
Ralf Hofheinz
Honoraria - Lilly
Consulting or Advisory Role - Lilly
 
Tanja Trarbach
No Relationships to Disclose
 
Ullrich Graeven
Honoraria - Boehringer Ingelheim; Daiichi Sankyo; Sirtex Medical
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Hexal; Merck KGaA
Travel, Accommodations, Expenses - Amgen; Merck KGaA
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Thorsten Oliver Goetze
Honoraria - Bayer; Celgene; Lilly; Merck Sharp & Dome; SERVIER; Shire
Speakers' Bureau - Lilly; Merck Sharp & Dome; Miami Cancer Institute
 
Volker A. Hagen
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson
Honoraria - Celgene; Pfizer; Roche
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; iOMEDICO; Janssen-Cilag; Roche
 
Susen Burock
No Relationships to Disclose
 
Albrecht Hoffmeister
No Relationships to Disclose
 
Tobias Nicolaas Dechow
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Isabel Virchow
No Relationships to Disclose
 
Jens T Siveke
Consulting or Advisory Role - Baxalta; Celgene; Roche; Shire
Research Funding - Bristol-Myers Squibb; Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Roche; Shire
 
Salah-Eddin Al-Batran
Leadership - IKF Klinische Krebsforschung
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience; Promedior; Roche
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma
 
Martin H. Schuler
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)